Antisense oligonucleotides and prevention of tumor growth: A different approach and proposal for a new method

Medical Hypotheses

Volumn 64, Issue 2, 2005, Pages 328-332

  Yildiz, Deniz ^a   Oztas, Haydar ^a   Hilal Ates, Buse ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; ENDONUCLEASE; MESSENGER RNA;

ARTICLE; CANCER GROWTH; CANCER PREVENTION; GENE EXPRESSION; GENE ISOLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; TUMOR CELL;

GENE THERAPY; GENETIC ENGINEERING; GROWTH INHIBITORS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENES; RNA, MESSENGER;

EID: 11144277901     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.06.029     Document Type: Article

References (33)

1. G.L. Nicolsan Cell surface molecules and tumor metastasis, regulation of metastatic phenotypic diversity Exp Cell Res 150 1984 3 22
2. M. Magnano, G. Bongioannini, W. Lerda, M.B. Galvagno, E. Tondolo, G. Canale, B. Capogrosso, P.P. Delsanto, M. Scalerandi, and G.P. Pescarmona A physical-based model for the simulation of neoplastic growth and metastasis J Surg Oncol 74 2000 122 129
3. H. Lodish, A. Berk, S.L. Zipursky, P. Matsudaira, D. Baltimore, and J. Darnell Molecular cell biology 2000 W.H. Freeman and Company p. 1055-61
4. M.B. Sporn, and A.B. Roberts Autocrine growth factors and cancer Nature 313 1985 745 747
5. I.F. Tannock, and R.P. Hill The basic science of oncology 1992 McGraw-Hill Inc New York
6. S. Mazurek, E. Eigenbrodt, K. Failing, and P. Steinberg Alterations in glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells J Cell Physiol 181 1999 136 146
7. L.G. Baggetto Deviant energetic metabolism of glycolytic cancer cells Biochimie 74 1992 959 974
8. M. Board, S. Humm, and E.A. Newsholme Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells Biochem J 265 1990 503 509
9. S.P. Mathupala, A. Rempel, and P.L. Pedersen Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase J Bioenerget Biomemb 29 1997 339 343
10. H. Shim, C. Dolde, B.C. Lewis, C.S. Wu, G. Dang, R.A. Jungmann, D.A. Ricardo, and C.V. Dang c-Myc transactivation of LDH-A: implications for tumor metabolism and growth Proc Natl Acad Sci USA 94 1997 6658 6663
11. C.V. Dang, B.C. Lewis, C. Dolde, G. Dang, and H. Shim Oncogenes in tumor metabolism, tumorigenesis, and apoptosis J Bioenerget Biomemb 29 1997 345 354
12. T.A.D. Smith Mammalian hexokinases and their abnormal expression in cancer Br J Biomed Sci 57 2000 170 178
13. D.M. Parry, and P.L. Pedersen Intracellular localization and properties of particulate hexokinase in the novikoff ascites tumor, evidence for an outer mitochondrial membrane location J Biol Chem 258 1983 10904 10912
14. A. Rempel, S.P. Mathupala, C.A. Griffin, A.L. Hawkins, and P.L. Pedersen Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase Cancer Res 56 1996 2468 2471
15. L.G. Baggetto, and A.L. Lehninger Isolated tumoral pyruvate dehydrogenase can synthesize acetoin which inhibits pyruvate oxidation as well as other aldehydes Biochem Biophys Res Commun 145 1987 153 159
16. M. Miralpeix, J.A. Bieto, R. Bartrons, and J.M. Argiles The impairment of respiration by glycolysis in the Lewis lung carcinoma Cancer Lett 50 1990 173 178
17. S. Mazurek, C.B. Boschek, and E. Eigenbrodt The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy J Bioenerget Biomembr 29 1997 315 330
18. M. Barbacid Oncogenes and human cancer: cause or consequence Carcinogenesis 7 1986 1037 1042
19. C.V. Dang, and G.L. Semenza Oncogenic alterations of metabolism TIBS 1999 68 72
20. L. Lombardi, E.W. Newcomb, and R.D. Favera Pathogenesis of burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts Cell 49 1987 161 170
21. D. Hrouda, M. Perry, and A.G. Dalgleish Gene therapy for prostate cancer Semin Oncol 26 1999 455 471
22. A.S. Gauchez, A.M. D'Hardemare, J. Lunardi, J.P. Vuillez, and D. Fagret Potential use of radiolabeled antisense oligonucleotides in oncology Anticancer Res 19 1999 4989 4998
23. F.E. Cotter Antisense therapy of hematologic malignancies Semin Hematol 36 1999 9 14
24. F.E. Cotter, J. Waters, and D. Cunningham Human Bcl-2 antisense therapy for lymphomas Biochim Biophys Acta 1489 1999 97 106
25. A. Bloem, and H. Lockhorst Bcl-2 antisense therapy in multiple myeloma Path Biol 47 1999 216 220
26. Y.S. Cho-Chung Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatment Pharmacol Ther 82 1999 437 449
27. R.J. MacDonald, G.H. Swift, A.E. Przybyla, and J.M. Chirgwin Isolation of RNA using guanidium salts Meth Enzymol 152 1987 219 227
28. S.M. Hedrick, D.I. Cohen, E.A. Nielsen, and M.M. Davis Isolation of cDNA clones encoding T cell-specific membrane-associated proteins Nature 308 1984 149 153
29. J.H. Han, C. Stratowa, and W.J. Rutter Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning Biochemistry 26 1987 1617 1625
30. U. Gubler, and B.J. Hoffman A simple and very efficient method for generating cDNA libraries Gene 25 1983 263 269
31. T.A. Rhyner, N.F. Biguet, S. Berrard, A.A. Borbély, and J. Mallet An efficient approach for the selective isolation of specific transcripts from complex brain mRNA populations J Neurosci Res 16 1986 167 181
32. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual vol. 2 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor (NY) p. 8.11-8.21
33. A.M. Maxam, and W. Gilbert Sequencing end-labeled DNA with base-specific chemical cleavages Meth Enzymol 65 1980 499 560